<DOC>
	<DOCNO>NCT00006341</DOCNO>
	<brief_summary>RATIONALE : The use dentures dental implant may help maintain chew speak ability follow surgery remove tumor mouth . PURPOSE : Phase II trial study effectiveness dentures dental implant maintain ability chew speak patient undergo surgery mouth cancer .</brief_summary>
	<brief_title>Dentures Dental Implants Treating Patients Undergoing Surgery Mouth Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether conventional implant support dental prosthesis current surgical reconstructive procedure restore oral function quality life pre-cancer surgery level patient early oral cancer . OUTLINE : Patients complete series objective subjective functional test , questionnaire , baseline examination . Within 1-5 day , patient undergo composite resection , include reconstructive surgery mandibulectomy group . Patients maxillectomy group receive immediate maxillary surgical obturator . Approximately 6 week ablative surgery , patient receive radiotherapy 5-7 week . Patients receive 2-4 implant 12-16 week completion radiotherapy 8-16 week ablative surgery . Patients receive conventional denture 4-22 week implant surgery . Implants expose 27-48 week placement abutment connect fabricate dental prosthesis . Approximately 8 week need fabricate implant support prosthesis . Patients complete quality life questionnaire prior 8-21 week surgery , 16 week conventional denture insertion , 16 week implant support prosthesis insertion . Patients follow every 6 month least 3 year . PROJECTED ACCRUAL : A total 62 patient ( 22 require maxillectomy 40 require mandibulectomy ) accrue study within 42 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis early oral cancer lesion require one following : Partial total unilateral maxillectomy OR Partial lateral mandibulectomy without partial glossectomy Edentulous edentulous maxillary arch prior ablative surgery ( maxillectomy group ) Partial mandibulectomy leave condyle intact bilaterally ( mandibulectomy group ) Must sufficient bone select implant site accommodate 24 implant least 10 mm length No temporomandibular dysfunction and/or functionally restrictive opening No requirement total glossectomy , reconstructive maxillary surgery , maxillary sinus lift No requirement radiotherapy mandibular reconstructive surgery PATIENT CHARACTERISTICS : Age : 35 80 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No oral discomfort would preclude study No complication ablative reconstructive surgery would preclude dental rehabilitation implant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior concurrent radiotherapy great 5,500 cGY potential implant site Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>stage I lip oral cavity cancer</keyword>
	<keyword>stage II lip oral cavity cancer</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
</DOC>